BMC CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2023-10-12 ms9000001935138113 来自北京

偏重的研究方向：胃肠肿瘤
经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2024-02-21 ms1000001009157638

审稿速度:6.0
经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2024-02-20 524542323 来自广东省

审稿速度:24.0
经验分享：2023.10.1投稿，至今还是没有消息。

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2024-01-19 硅星来自北京

各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2023-07-23 ms9000001935138113 来自北京

偏重的研究方向：肿瘤
经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2024-01-19 硅星来自北京

各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了

27 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2023-04-23 1479422cm92暂无昵称来自青海省

纯生信的文章不知道是不是接受

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2024-01-11 ms4000001896463781 来自北京

偏重的研究方向：肿瘤
经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了

26 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2023-04-06 YG社长候选人来自四川省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：影像组学;乳腺癌;病理组学
经验分享：
Submission accepted
06 Apr 2023
Submission under peer review
23 Mar 2023
Submission passed technical check
23 Mar 2023
Amendment received
23 Mar 2023
Revision received
23 Mar 2023
Submission under peer review
01 Mar 2023
Technical check
Submission passed technical check
01 Mar 2023
Amendment received
25 Feb 2023
Amendment received
22 Feb 2023
Submission is under technical check
15 Feb 2023
Submission received
15 Feb 2023
刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。

73 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2162313, encodeId=19a82162313dc, content=偏重的研究方向：胃肠肿瘤 经验分享：各位前辈，请问该杂志一般送几个reviewer？我的状态为“1 reviewer report received”20天了。一般审多久会返给editor呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Thu Oct 12 09:43:17 CST 2023, time=2023-10-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2188544, encodeId=7d4921885449a, content=审稿速度:6.0 经验分享：Reviewer reports received / Ready for editor’s decision已经快一个月了，还没信, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e8f8631531, createdName=ms1000001009157638, createdTime=Wed Feb 21 18:36:26 CST 2024, time=2024-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2188302, encodeId=5f282188302b1, content=审稿速度:24.0 经验分享：2023.10.1投稿，至今还是没有消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=591c1396579, createdName=524542323, createdTime=Tue Feb 20 12:45:31 CST 2024, time=2024-02-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2182678, encodeId=0abe21826e89d, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:06:36 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2149404, encodeId=9d92214940426, content=偏重的研究方向：肿瘤 经验分享：请问各位大佬，大家的editor invited持续了多久？ editor invited之后的状态就是编辑评估后送外审了吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=700f8363924, createdName=ms9000001935138113, createdTime=Sun Jul 23 08:15:20 CST 2023, time=2023-07-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2182679, encodeId=68f421826e939, content=各位大佬，请问这个杂志的质控过程一般持续多久啊，已经卡了12天了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84225471684, createdName=硅星, createdTime=Fri Jan 19 17:07:00 CST 2024, time=2024-01-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127798, encodeId=80c2212e798cc, content=纯生信的文章不知道是不是接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60ed5227883, createdName=1479422cm92暂无昵称, createdTime=Sun Apr 23 10:33:21 CST 2023, time=2023-04-23, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2180808, encodeId=c72f2180808db, content=偏重的研究方向：肿瘤 经验分享：请问下大家，纯生信文章还能投这本吗，孩子急着毕业，真的是哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c87b6545229, createdName=ms4000001896463781, createdTime=Thu Jan 11 16:44:57 CST 2024, time=2024-01-11, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2124088, encodeId=f93f2124088e4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：影像组学;乳腺癌;病理组学 经验分享： Submission accepted 06 Apr 2023 Submission under peer review 23 Mar 2023 Submission passed technical check 23 Mar 2023 Amendment received 23 Mar 2023 Revision received 23 Mar 2023 Submission under peer review 01 Mar 2023 Technical check Submission passed technical check 01 Mar 2023 Amendment received 25 Feb 2023 Amendment received 22 Feb 2023 Submission is under technical check 15 Feb 2023 Submission received 15 Feb 2023 刚开始投的时候看了论坛也比较忐忑，但其实时间也很快，不到两个月就接受了同行评审只用了10天左右，以上是我的时间路径供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230326/4f513275f85942e79c2aee2c7fa51855/91079839e40b4a49bc084a8ec14053b3.jpg, createdBy=35095644735, createdName=YG社长候选人, createdTime=Thu Apr 06 13:33:17 CST 2023, time=2023-04-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2173365, encodeId=759a21e33655e, content=外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭, , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=542a5391598, createdName=ms9000000228172903, createdTime=Wed Dec 06 21:40:01 CST 2023, time=2023-12-06, status=1, ipAttribution=甘肃省)]

2023-12-06 ms9000000228172903 来自甘肃省

外审第一天就有个审稿人返回意见了，这是不是GG了，/大哭, /大哭,

53 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务